Cargando…
Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
Background and Objectives: We have recently reported that stains have calcium channel blocking activity in isolated jejunal preparations. In this study, we examined the effects of atorvastatin and fluvastatin on blood vessels for a possible vasorelaxant effect. We also studied the possible additiona...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303907/ https://www.ncbi.nlm.nih.gov/pubmed/37374229 http://dx.doi.org/10.3390/medicina59061023 |
_version_ | 1785065386227531776 |
---|---|
author | Ali, Niaz Ali, Wajid Ullah, Abid Ahmad, Shujaat Alsaiari, Ahad Amer Almehmadi, Mazen Abdulaziz, Osama Allahyani, Mamdouh Aljuaid, Abdulelah |
author_facet | Ali, Niaz Ali, Wajid Ullah, Abid Ahmad, Shujaat Alsaiari, Ahad Amer Almehmadi, Mazen Abdulaziz, Osama Allahyani, Mamdouh Aljuaid, Abdulelah |
author_sort | Ali, Niaz |
collection | PubMed |
description | Background and Objectives: We have recently reported that stains have calcium channel blocking activity in isolated jejunal preparations. In this study, we examined the effects of atorvastatin and fluvastatin on blood vessels for a possible vasorelaxant effect. We also studied the possible additional vasorelaxant effect of atorvastatin and fluvastatin, in the presence of amlodipine, to quantify its effects on the systolic blood pressure of experimental animals. Materials and Methods: Atorvastatin and fluvastatin were tested in isolated rabbits’ aortic strip preparations using 80mM Potassium Chloride (KCl) induced contractions and 1 micro molar Norepinephrine (NE) induced contractions. A positive relaxing effect on 80 mM KCl induced contractions were further confirmed in the absence and presence of atorvastatin and fluvastatin by constructing calcium concentration response curves (CCRCs) while using verapamil as a standard calcium channel blocker. In another series of experiments, hypertension was induced in Wistar rats and different test concentrations of atorvastatin and fluvastatin were administered in their respective EC(50) values to the test animals. A fall in their systolic blood pressure was noted using amlodipine as a standard vasorelaxant drug. Results: The results show that fluvastatin is more potent than amlodipine as it relaxed NE induced contractions where the amplitude reached 10% of its control in denuded aortae. Atorvastatin relaxed KCL induced contractions with an amplitude reaching 34.4% of control response as compared to the amlodipine response, i.e., 39.1%. A right shift in the EC(50) (Log Ca++ M) of Calcium Concentration Response Curves (CCRCs) implies that statins have calcium channel blocking activity. A right shift in the EC(50) of fluvastatin with relatively less EC(50) value (−2.8 Log Ca++ M) in the presence of test concentration (1.2 × 10(−7) M) of fluvastatin implies that fluvastatin is more potent than atorvastatin. The shift in EC(50) resembles the shift of Verapamil, a standard calcium channel blocker (−1.41 Log Ca++ M). Conclusions: Atorvastatin and fluvastatin relax the aortic strip preparations predominantly through the inhibition of voltage gated calcium channels in high molar KCL induced contractions. These statins also inhibit the effects of NE induced contractions. The study also confirms that atorvastatin and fluvastatin potentiate blood pressure lowering effects in hypertensive rats. |
format | Online Article Text |
id | pubmed-10303907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103039072023-06-29 Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon Ali, Niaz Ali, Wajid Ullah, Abid Ahmad, Shujaat Alsaiari, Ahad Amer Almehmadi, Mazen Abdulaziz, Osama Allahyani, Mamdouh Aljuaid, Abdulelah Medicina (Kaunas) Article Background and Objectives: We have recently reported that stains have calcium channel blocking activity in isolated jejunal preparations. In this study, we examined the effects of atorvastatin and fluvastatin on blood vessels for a possible vasorelaxant effect. We also studied the possible additional vasorelaxant effect of atorvastatin and fluvastatin, in the presence of amlodipine, to quantify its effects on the systolic blood pressure of experimental animals. Materials and Methods: Atorvastatin and fluvastatin were tested in isolated rabbits’ aortic strip preparations using 80mM Potassium Chloride (KCl) induced contractions and 1 micro molar Norepinephrine (NE) induced contractions. A positive relaxing effect on 80 mM KCl induced contractions were further confirmed in the absence and presence of atorvastatin and fluvastatin by constructing calcium concentration response curves (CCRCs) while using verapamil as a standard calcium channel blocker. In another series of experiments, hypertension was induced in Wistar rats and different test concentrations of atorvastatin and fluvastatin were administered in their respective EC(50) values to the test animals. A fall in their systolic blood pressure was noted using amlodipine as a standard vasorelaxant drug. Results: The results show that fluvastatin is more potent than amlodipine as it relaxed NE induced contractions where the amplitude reached 10% of its control in denuded aortae. Atorvastatin relaxed KCL induced contractions with an amplitude reaching 34.4% of control response as compared to the amlodipine response, i.e., 39.1%. A right shift in the EC(50) (Log Ca++ M) of Calcium Concentration Response Curves (CCRCs) implies that statins have calcium channel blocking activity. A right shift in the EC(50) of fluvastatin with relatively less EC(50) value (−2.8 Log Ca++ M) in the presence of test concentration (1.2 × 10(−7) M) of fluvastatin implies that fluvastatin is more potent than atorvastatin. The shift in EC(50) resembles the shift of Verapamil, a standard calcium channel blocker (−1.41 Log Ca++ M). Conclusions: Atorvastatin and fluvastatin relax the aortic strip preparations predominantly through the inhibition of voltage gated calcium channels in high molar KCL induced contractions. These statins also inhibit the effects of NE induced contractions. The study also confirms that atorvastatin and fluvastatin potentiate blood pressure lowering effects in hypertensive rats. MDPI 2023-05-25 /pmc/articles/PMC10303907/ /pubmed/37374229 http://dx.doi.org/10.3390/medicina59061023 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ali, Niaz Ali, Wajid Ullah, Abid Ahmad, Shujaat Alsaiari, Ahad Amer Almehmadi, Mazen Abdulaziz, Osama Allahyani, Mamdouh Aljuaid, Abdulelah Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon |
title | Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon |
title_full | Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon |
title_fullStr | Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon |
title_full_unstemmed | Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon |
title_short | Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon |
title_sort | atorvastatin and fluvastatin potentiate blood pressure lowering effect of amlodipine through vasorelaxant phenomenon |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303907/ https://www.ncbi.nlm.nih.gov/pubmed/37374229 http://dx.doi.org/10.3390/medicina59061023 |
work_keys_str_mv | AT aliniaz atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT aliwajid atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT ullahabid atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT ahmadshujaat atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT alsaiariahadamer atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT almehmadimazen atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT abdulazizosama atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT allahyanimamdouh atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon AT aljuaidabdulelah atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon |